Render, Virtuals Protocol and Artificial Superintelligence Alliance tokens lead AI’s bounce Gains come as Bitcoin breaks above $92,000 amid the geopolitical situationRender, Virtuals Protocol and Artificial Superintelligence Alliance tokens lead AI’s bounce Gains come as Bitcoin breaks above $92,000 amid the geopolitical situation

AI tokens lead crypto rebound as Bitcoin Breaks $92,000, Render jumps 15%

2026/01/05 17:54
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]
  • Render, Virtuals Protocol and Artificial Superintelligence Alliance tokens lead AI’s bounce
  • Gains come as Bitcoin breaks above $92,000 amid the geopolitical situation in Venezuela.
  • RENDER price could rally to $3-$5 region in the short term.

AI tokens have joined memecoins in starting the year higher, with Render price set for a potential retest of $3.

This comes as the cryptocurrency market kicks off 2026 with renewed vigor. Bitcoin has broken above $92,000 while Ethereum bulls have eyes on strengthening above $3,100.

Amid this, artificial intelligence-related tokens lead the broader recovery in altcoins, which in the past 24 hours, includes major gains for Virtuals Protocol and Artificial Superintelligence Alliance.

Pepe soared to lead memecoin’s rebound last week.

RENDER price gains 15% as AI tokens lead crypto bounce

The Render project offers a decentralized GPU rendering network, and ranks as one of the top AI tokens in the crypto space.

Amid an overall spike for AI coins, its native token has surged by more than 15%.

This move in the past 24 hours has seen the token top the $2.10 mark, with the uptick riding an intraday pump in buying pressure.

Per CoinMarketCap, over $139 million in Render has been traded in this period.

On a weekly basis, RENDER has posted over 56% gains. This aligns with a broader rebound in the AI crypto segment, where related projects have demonstrated even stronger momentum.

For instance, FET has advanced by more than 15% in the past day and 30% this past week.

Elsewhere, Virtuals Protocol (VIRTUAL) has rallied more than 25% and 51% in the same time frames, respectively.

Render price hovered near $2.07 at the time of writing.

Bitcoin price buoys altcoins

The gains for RENDER and other AI tokens have materialized against a backdrop of positive developments in the broader market.

After struggling at the end of 2025, Bitcoin is showing strength as the price breaks above $92,000.

BTC’s upside looks to have bolstered risk appetite across digital assets, even as geopolitical tensions escalate.

Recent US military actions in Venezuela, including strikes and the capture of President Nicolás Maduro, have introduced uncertainty.

However, market participants appear to view these events as contained.

Bulls are prioritizing Bitcoin’s strength and potential implications for energy markets over immediate risk-off sentiment.

RENDER price forecast

As the new year unfolds, AI tokens are joining memecoins in delivering robust early performance.

While investors could yet rotate into top coins, the early moves have the likes of Pepe (PEPE) and Shiba Inu (SHIB) ranking among the top weekly performers.

Render Price Chart Render price chart by TradingView

Retail enthusiasm amid some level of certainty will be good for small caps.

In this case, RENDER could eye a breakout to $3 or higher.

The charts show technical indicators pointing to constructive momentum.

A look at the weekly Relative Strength Index (RSI) suggests a potential upside continuation.

Buyers may nonetheless have to contend with the resistance zone highlighted by the weekly moving average.

The post AI tokens lead crypto rebound as Bitcoin Breaks $92,000, Render jumps 15% appeared first on CoinJournal.

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09